These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3700690)

  • 1. Labetalol in the treatment of essential hypertension: a single-blind dose ranging study.
    Dux S; Grosskopf I; Boner G; Rosenfeld JB
    J Clin Pharmacol; 1986; 26(5):346-50. PubMed ID: 3700690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
    Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
    Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Step II treatment with labetalol for essential hypertension.
    Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
    Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of labetalol compared to hydrochlorothiazide in hypertensive black patients.
    Lucas C; Jenkins P; Mendels J; Due D; Forbes WP; Sirgo MA
    J Natl Med Assoc; 1991 Oct; 83(10):866-71. PubMed ID: 1800760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with labetalol in hypertension.
    Bolli P; Waal-Manning J; Wood AJ; Simpson FO
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):765-71. PubMed ID: 791330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant therapy with labetalol and hydrochlorothiazide in moderate to moderately severe essential hypertension.
    Kochar MS; Tyson J; Kalbfleisch JH
    J Clin Pharmacol; 1985 Sep; 25(6):433-6. PubMed ID: 3902912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of labetalol alone and combined with chlorthalidone in essential hypertension: a double-blind multicentre controlled study.
    Lechi A; Pomari S; Berto R; Buniotto P; Parrinello A; Marini F; Cogo L; Tomasi A; Baretta G
    Eur J Clin Pharmacol; 1982; 22(4):289-93. PubMed ID: 7049710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of labetalol and hydrochlorothiazide in elderly patients with hypertension using 24-hour ambulatory blood pressure monitoring.
    Weidler DJ; Vidt DG; Toth PD; Due DL; Sirgo MA
    J Clin Pharmacol; 1990 Jun; 30(6):524-32. PubMed ID: 2355103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind study of dilevalol and captopril, both in combination with hydrochlorothiazide, in patients with moderate to severe hypertension.
    McGrath BP; Matthews PG; Louis W; Howes L; Whitworth JA; Kincaid-Smith PS; Fraser I; Scheinkestel C; MacDonald G; Rallings M
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):831-8. PubMed ID: 1703608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Labetalol in essential hypertension.
    Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
    J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
    Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
    Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of intravenous labetalol and follow-up therapy with oral labetalol.
    Vlachakis ND; Maronde RF; Maloy JW; Medakovic M; Kassem N
    Clin Pharmacol Ther; 1985 Nov; 38(5):503-8. PubMed ID: 4053487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
    Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
    Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
    Wallin JD; Wilson D; Winer N; Maronde RF; Michelson EL; Langford H; Maloy J; Poland M
    Am J Med; 1983 Oct; 75(4A):87-94. PubMed ID: 6356903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous dilevalol. Effects of the R-R optical isomer of labetalol in patients with severe hypertension.
    Wallin JD; Cook ME; Clifton GG; Blasucci DJ; Poland M
    Arch Intern Med; 1988 Mar; 148(3):534-8. PubMed ID: 3277568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.